Literature DB >> 30460580

Association Between TG-to-HDL-C Ratio and In-Stent Stenosis Under Optical Coherence Tomography Guidance.

Ya Li1,2, Peng Jin1,3, Fangjie Hou1,4, Yujie Zhou5.   

Abstract

We determined the relevance between the TG-to-HDL-C ratio and stent restenosis. Ninety-nine patients with in-stent stenosis (ISR) who were admitted to An Zhen Hospital in Beijing between April 2014 and June 2017 were selected. At the same time, 122 patients with coronary stenosis <50% were selected. All patients were tested for TG, HDL-C, and TG/HDL-C ratio. Optical coherence tomography (OCT) can assess microscopic status in all ISR patients. The proportion of male and Diabetic patients were significantly higher for ISR. There were differences in the prevalence of cigarette smokers among the different tissue types, among which the layered tissue type accounted for the highest proportion. In logistic regression analysis the study showed that male, diabetes mellitus, and the TG/HDL-C ratio are risk factors for ISR. The ISR ROC was 0.725 based on the TG/HDL-C ratio diagnosis. It is related to the degree of coronary stenosis and effective in diagnosing in-stent stenosis in ISR.

Entities:  

Keywords:  Coronary heart disease; In-stent restenosis; Optical coherence tomography; TG-to-HDL ratio

Mesh:

Substances:

Year:  2018        PMID: 30460580     DOI: 10.1007/s10916-018-1119-y

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  27 in total

1.  Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.

Authors:  Sebastian Kufner; Salvatore Cassese; Marco Valeskini; Franz-Josef Neumann; Stefanie Schulz-Schüpke; Petra Hoppmann; Massimiliano Fusaro; Heribert Schunkert; Karl-Ludwig Laugwitz; Adnan Kastrati; Robert A Byrne
Journal:  JACC Cardiovasc Interv       Date:  2015-05-20       Impact factor: 11.195

2.  The association between the ratio of triglyceride to HDL-C and insulin resistance according to waist circumference in a rural Korean population.

Authors:  H-T Kang; J-H Yoon; J-Y Kim; S-K Ahn; J A Linton; S-B Koh; J-K Kim
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-07-18       Impact factor: 4.222

3.  Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.

Authors:  Fumitaka Tanaka; Shinji Makita; Toshiyuki Onoda; Kozo Tanno; Masaki Ohsawa; Kazuyoshi Itai; Kiyomi Sakata; Shin-Ichi Omama; Yuki Yoshida; Kuniaki Ogasawara; Akira Ogawa; Yasuhiro Ishibashi; Toru Kuribayashi; Akira Okayama; Motoyuki Nakamura
Journal:  Am J Cardiol       Date:  2013-07-04       Impact factor: 2.778

4.  Mortality risk of triglyceride levels in patients with coronary artery disease.

Authors:  Takatoshi Kasai; Katsumi Miyauchi; Naotake Yanagisawa; Kan Kajimoto; Naozumi Kubota; Manabu Ogita; Shuta Tsuboi; Atsushi Amano; Hiroyuki Daida
Journal:  Heart       Date:  2012-09-26       Impact factor: 5.994

5.  PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis.

Authors:  H Uthoff; D Staub; T Socrates; A Meyerhans; B Bundi; H P Schmid; B Frauchiger
Journal:  Vasa       Date:  2010-11       Impact factor: 1.961

6.  Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.

Authors:  Takeshi Tada; Kazushige Kadota; Shingo Hosogi; Koshi Miyake; Masanobu Ohya; Hideo Amano; Yu Izawa; Takenori Kanazawa; Shunsuke Kubo; Tahei Ichinohe; Yusuke Hyoudou; Yuki Hayakawa; Mahmoud Mohamed Hassan Sabbah; Suguru Otsuru; Daiji Hasegawa; Seiji Habara; Hiroyuki Tanaka; Yasushi Fuku; Harumi Katoh; Tsuyoshi Goto; Kazuaki Mitsudo
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03-09       Impact factor: 6.875

7.  Triglyceride-to-HDL cholesterol ratio. Predictive value for CHD severity and new-onset heart failure.

Authors:  Z Yunke; L Guoping; C Zhenyue
Journal:  Herz       Date:  2013-04-17       Impact factor: 1.443

8.  Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.

Authors:  Katsuaki Yokoyama; Shigemasa Tani; Rei Matsuo; Naoya Matsumoto
Journal:  Heart Vessels       Date:  2018-08-23       Impact factor: 2.037

9.  Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.

Authors:  Nadeem Sarwar; Manjinder S Sandhu; Sally L Ricketts; Adam S Butterworth; Emanuele Di Angelantonio; S Matthijs Boekholdt; Willem Ouwehand; Hugh Watkins; Nilesh J Samani; Danish Saleheen; Debbie Lawlor; Muredach P Reilly; Aroon D Hingorani; Philippa J Talmud; John Danesh
Journal:  Lancet       Date:  2010-05-08       Impact factor: 79.321

10.  Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults.

Authors:  Miguel Murguía-Romero; J Rafael Jiménez-Flores; Santiago C Sigrist-Flores; Miguel A Espinoza-Camacho; Mayra Jiménez-Morales; Enrique Piña; A René Méndez-Cruz; Rafael Villalobos-Molina; Gerald M Reaven
Journal:  J Lipid Res       Date:  2013-07-17       Impact factor: 5.922

View more
  2 in total

1.  The rs4783961 and rs708272 genetic variants of the CETP gene are associated with coronary artery disease, but not with restenosis after coronary stenting.

Authors:  Gilberto Vargas-Alarcón; Oscar Pérez-Méndez; Rosalinda Posadas-Sánchez; Marco A Peña-Duque; Marco A Martínez-Ríos; Hilda Delgadillo-Rodriguez; José M Fragoso
Journal:  Arch Cardiol Mex       Date:  2022-07-01

2.  Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis.

Authors:  Yuan Fu; Yixing Yang; Chen Fang; Xinming Liu; Ying Dong; Li Xu; Mulei Chen; Kun Zuo; Lefeng Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.